BACKGROUND: Age, clinical presentation and echocardiographic parameters are important factors in the decision on an individualized therapeutic strategy for patients with aortic stenosis (AS). Less is known about this information in a non-selected non-biased cohort. METHODS: We performed a retrospective, systematic analysis of patients admitted to our hospital from 1/1/2014 to 1/6/2018 with the diagnosis of AS. We collected demographic, clinical and echocardiographic parameters. All patients were evaluated and treated in one single institution by experienced cardiologists. We classified patients into 4 age groups to compare the above-mentioned variables. Category A: patients younger than 65 years, category B age between 65-74, category C age between 75-84, and category D patients older 85. RESULTS: We included 321 adults with AS in our study. There was a significant correlation between the aortic valve area, aortic velocity (Vmax), aortic pressure gradients (PMax) and age. The AVA decreased, Vmax and PMax increased with age (P=0.001, P=0.042 and P=0.017, respectively). 74.1% of all patients were symptomatic, but there were no differences between the age categories (P=0.406). The incidence of cardiovascular comorbidities was high throughout all age categories. Forty-four point five percent of all patients had a coronary artery disease, but there were no differences between the age categories (P=0.221). Echocardiographic aspect of AS was similar in all age groups except the right ventricular pressure (RVP): RVP was significantly higher in patients younger than 65 years. CONCLUSIONS: Based on our results, we conclude that age is a weak parameter for making decisions about the optimal AS therapy. AVAs in AS decreases moderately with age. Age does not impact any clinical or echocardiographic parameters. Cardiovascular diseases and symptomatic AS are found in all age categories. 2019 Cardiovascular Diagnosis and Therapy. All rights reserved.
BACKGROUND: Age, clinical presentation and echocardiographic parameters are important factors in the decision on an individualized therapeutic strategy for patients with aortic stenosis (AS). Less is known about this information in a non-selected non-biased cohort. METHODS: We performed a retrospective, systematic analysis of patients admitted to our hospital from 1/1/2014 to 1/6/2018 with the diagnosis of AS. We collected demographic, clinical and echocardiographic parameters. All patients were evaluated and treated in one single institution by experienced cardiologists. We classified patients into 4 age groups to compare the above-mentioned variables. Category A: patients younger than 65 years, category B age between 65-74, category C age between 75-84, and category D patients older 85. RESULTS: We included 321 adults with AS in our study. There was a significant correlation between the aortic valve area, aortic velocity (Vmax), aortic pressure gradients (PMax) and age. The AVA decreased, Vmax and PMax increased with age (P=0.001, P=0.042 and P=0.017, respectively). 74.1% of all patients were symptomatic, but there were no differences between the age categories (P=0.406). The incidence of cardiovascular comorbidities was high throughout all age categories. Forty-four point five percent of all patients had a coronary artery disease, but there were no differences between the age categories (P=0.221). Echocardiographic aspect of AS was similar in all age groups except the right ventricular pressure (RVP): RVP was significantly higher in patients younger than 65 years. CONCLUSIONS: Based on our results, we conclude that age is a weak parameter for making decisions about the optimal AS therapy. AVAs in AS decreases moderately with age. Age does not impact any clinical or echocardiographic parameters. Cardiovascular diseases and symptomatic AS are found in all age categories. 2019 Cardiovascular Diagnosis and Therapy. All rights reserved.
Authors: Joanna L d'Arcy; Sean Coffey; Margaret A Loudon; Andrew Kennedy; Jonathan Pearson-Stuttard; Jacqueline Birks; Eleni Frangou; Andrew J Farmer; David Mant; Jo Wilson; Saul G Myerson; Bernard D Prendergast Journal: Eur Heart J Date: 2016-06-26 Impact factor: 29.983
Authors: Per O Vandvik; Catherine M Otto; Reed A Siemieniuk; Rodrigo Bagur; Gordon H Guyatt; Lyubov Lytvyn; Richard Whitlock; Trond Vartdal; David Brieger; Bert Aertgeerts; Susanna Price; Farid Foroutan; Michael Shapiro; Ray Mertz; Frederick A Spencer Journal: BMJ Date: 2016-09-28
Authors: Thomas Walther; Christian W Hamm; Gerhard Schuler; Alexander Berkowitsch; Joachim Kötting; Norman Mangner; Harald Mudra; Andreas Beckmann; Jochen Cremer; Armin Welz; Rüdiger Lange; Karl-Heinz Kuck; Friedrich W Mohr; Helge Möllmann Journal: J Am Coll Cardiol Date: 2015-03-15 Impact factor: 24.094
Authors: Helmut Baumgartner; Volkmar Falk; Jeroen J Bax; Michele De Bonis; Christian Hamm; Per Johan Holm; Bernard Iung; Patrizio Lancellotti; Emmanuel Lansac; Daniel Rodriguez Muñoz; Raphael Rosenhek; Johan Sjögren; Pilar Tornos Mas; Alec Vahanian; Thomas Walther; Olaf Wendler; Stephan Windecker; Jose Luis Zamorano Journal: Eur Heart J Date: 2017-09-21 Impact factor: 29.983
Authors: Jonathan Afilalo; Sandra Lauck; Dae H Kim; Thierry Lefèvre; Nicolo Piazza; Kevin Lachapelle; Giuseppe Martucci; Andre Lamy; Marino Labinaz; Mark D Peterson; Rakesh C Arora; Nicolas Noiseux; Andrew Rassi; Igor F Palacios; Philippe Généreux; Brian R Lindman; Anita W Asgar; Caroline A Kim; Amanda Trnkus; José A Morais; Yves Langlois; Lawrence G Rudski; Jean-Francois Morin; Jeffrey J Popma; John G Webb; Louis P Perrault Journal: J Am Coll Cardiol Date: 2017-07-07 Impact factor: 24.094
Authors: Jocelyn M Beach; Tomislav Mihaljevic; Lars G Svensson; Jeevanantham Rajeswaran; Thomas Marwick; Brian Griffin; Douglas R Johnston; Joseph F Sabik; Eugene H Blackstone Journal: J Am Coll Cardiol Date: 2013-02-26 Impact factor: 24.094
Authors: Philippe Généreux; Gregg W Stone; Patrick T O'Gara; Guillaume Marquis-Gravel; Björn Redfors; Gennaro Giustino; Philippe Pibarot; Jeroen J Bax; Robert O Bonow; Martin B Leon Journal: J Am Coll Cardiol Date: 2016-04-02 Impact factor: 24.094
Authors: Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke Journal: PLoS Med Date: 2007-10-16 Impact factor: 11.069